Cellectis hails success in ridding British infant of cancer
9 May 2016
Professor Waseem Qasim (UCL Institute of Child Health) has
used a new cell therapy developed by Cellectis to treat a second child with
a previously incurable form of leukaemia. Read: Financial Times